Injizierbare Füllmaterialien: Nebenwirkungen und Management

[1]  G. Gauglitz,et al.  German S2k guidelines for the therapy of pathological scars (hypertrophic scars and keloids) , 2012, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

[2]  Byung-Il Lee,et al.  Vascular complications of hyaluronic acid fillers and the role of hyaluronidase in management. , 2011, Journal of plastic, reconstructive & aesthetic surgery : JPRAS.

[3]  B. Rzany,et al.  Adverse reactions caused by consecutive injections of different fillers in the same facial region: risk assessment based on the results from the Injectable Filler Safety study , 2011, Journal of the European Academy of Dermatology and Venereology : JEADV.

[4]  T. Park,et al.  Clinical experience with hyaluronic acid-filler complications. , 2011, Journal of plastic, reconstructive & aesthetic surgery : JPRAS.

[5]  Rod J. Rohrich.  Introduction to the facial soft-tissue fillers conference supplement. , 2011, Journal of the American Academy of Dermatology.

[6]  Susan C. Taylor,et al.  Facial Soft-Tissue Fillers conference: Assessing the State of the Science. , 2011, Journal of the American Academy of Dermatology.

[7]  B. Rzany,et al.  Hyaluronidase in the correction of hyaluronic acid‐based fillers: a review and a recommendation for use , 2009, Journal of cosmetic dermatology.

[8]  W. Stolz,et al.  Electron Microscopic Documentation of Late Changes in Permanent Fillers and Clinical Management of Granulomas in Affected Patients , 2009, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[9]  Frank Bachmann,et al.  The Spectrum of Adverse Reactions After Treatment with Injectable Fillers in the Glabellar Region: Results from the Injectable Filler Safety Study , 2009, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[10]  T. Tolker-Nielsen,et al.  Detection of Bacteria by Fluorescence in Situ Hybridization in Culture‐Negative Soft Tissue Filler Lesions , 2009, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[11]  L. Christensen,et al.  Advanced Laser Techniques for Filler‐Induced Complications , 2009, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[12]  O. Chosidow,et al.  Facial Cosmetic Filler Injections as Possible Target for Systemic Sarcoidosis in Patients Treated with Interferon for Chronic Hepatitis C: Two Cases , 2008, Dermatology.

[13]  P. André.  Evaluation of the safety of a non‐animal stabilized hyaluronic acid (NASHA – Q‐Medical, Sweden) in European countries: a retrospective study from 1997 to 2001 , 2004, Journal of the European Academy of Dermatology and Venereology : JEADV.